Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same

Details for Australian Patent Application No. 2005260954 (hide)

Owner Taiho Pharmaceutical Co., Ltd.

Inventors Ushio, Takanori; Nagai, Keiko

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005260954

PCT Pub. Number WO2006/006616

Priority 2004-206046 13.07.04 JP

Filing date 13 July 2005

Wipo publication date 19 January 2006

Acceptance publication date 7 April 2011

International Classifications

C07C 381/12 (2006.01) Compounds containing carbon and sulfur and having functional groups not covered by groups

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

G01N 21/21 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light - Polarisation-affecting properties

G01N 23/20 (2006.01) Investigating or analysing materials by the use of wave or particle radiation not covered by group or , e.g. X-rays, neutrons - by using diffraction of the radiation, e.g. for investigating crystal structure

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/006616 Priority application(s): WO2006/006616

7 April 2011 Application Accepted

  Published as AU-B-2005260954

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005260955-Agent for promoting the recovery from dysfunction after the onset of central neurological disease

2005260935-Clathrate compound, method of controlling concentration of aqueous solution of agricultural-chemical active ingredient, and agricultural-chemical preparation